FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4311628032> ?p ?o ?g. }

• W4311628032 endingPage "8558" @default.
• W4311628032 startingPage "8558" @default.
• W4311628032 abstract "Commonly found colonizing the human microbiota, Candida albicans is a microorganism known for its ability to cause infections, mainly in the vulvovaginal region known as vulvovaginal candidiasis (VVC). This pathology is, in fact, one of the main C. albicans clinical manifestations, changing from a colonizer to a pathogen. The increase in VVC cases and limited antifungal therapy make C. albicans an increasingly frequent risk in women’s lives, especially in immunocompromised patients, pregnant women and the elderly. Therefore, it is necessary to develop new therapeutic options, especially those involving natural products associated with nanotechnology, such as lycopene and mesoporous silica nanoparticles. From this perspective, this study sought to assess whether lycopene, mesoporous silica nanoparticles and their combination would be an attractive product for the treatment of this serious disease through microbiological in vitro tests and acute toxicity tests in an alternative in vivo model of Galleria mellonella. Although they did not show desirable antifungal activity for VVC therapy, the present study strongly encourages the use of mesoporous silica nanoparticles impregnated with lycopene for the treatment of other human pathologies, since the products evaluated here did not show toxicity in the in vivo test performed, being therefore, a topic to be further explored." @default.
• W4311628032 created "2022-12-27" @default.
• W4311628032 creator A5009624165 @default.
• W4311628032 creator A5015836766 @default.
• W4311628032 creator A5022372740 @default.
• W4311628032 creator A5052073581 @default.
• W4311628032 creator A5056606353 @default.
• W4311628032 creator A5073382490 @default.
• W4311628032 creator A5085042254 @default.
• W4311628032 date "2022-12-05" @default.
• W4311628032 modified "2023-10-10" @default.
• W4311628032 title "Lycopene, Mesoporous Silica Nanoparticles and Their Association: A Possible Alternative against Vulvovaginal Candidiasis?" @default.
• W4311628032 cites W1205293764 @default.
• W4311628032 cites W1713687329 @default.
• W4311628032 cites W1896191564 @default.
• W4311628032 cites W1913337522 @default.
• W4311628032 cites W1971958512 @default.
• W4311628032 cites W1975154149 @default.
• W4311628032 cites W2028876251 @default.
• W4311628032 cites W2034791599 @default.
• W4311628032 cites W2046606679 @default.
• W4311628032 cites W2049767476 @default.
• W4311628032 cites W2070615039 @default.
• W4311628032 cites W2081736048 @default.
• W4311628032 cites W2083897883 @default.
• W4311628032 cites W2088408132 @default.
• W4311628032 cites W2119488829 @default.
• W4311628032 cites W2123286415 @default.
• W4311628032 cites W2133211453 @default.
• W4311628032 cites W2162123111 @default.
• W4311628032 cites W2185069069 @default.
• W4311628032 cites W221552897 @default.
• W4311628032 cites W2262970286 @default.
• W4311628032 cites W2279293317 @default.
• W4311628032 cites W2288375302 @default.
• W4311628032 cites W2314322923 @default.
• W4311628032 cites W2460618448 @default.
• W4311628032 cites W2519307991 @default.
• W4311628032 cites W2604788465 @default.
• W4311628032 cites W2612328945 @default.
• W4311628032 cites W2739660851 @default.
• W4311628032 cites W2772995273 @default.
• W4311628032 cites W2782051524 @default.
• W4311628032 cites W2784017415 @default.
• W4311628032 cites W2792067847 @default.
• W4311628032 cites W2859728640 @default.
• W4311628032 cites W2884354402 @default.
• W4311628032 cites W2886194746 @default.
• W4311628032 cites W2902839459 @default.
• W4311628032 cites W2924790514 @default.
• W4311628032 cites W3024163630 @default.
• W4311628032 cites W3026919773 @default.
• W4311628032 cites W3028573224 @default.
• W4311628032 cites W3038775853 @default.
• W4311628032 cites W3081817784 @default.
• W4311628032 cites W3084354259 @default.
• W4311628032 cites W3109707794 @default.
• W4311628032 cites W3111945008 @default.
• W4311628032 cites W3115197458 @default.
• W4311628032 cites W3123607403 @default.
• W4311628032 cites W3129088316 @default.
• W4311628032 cites W3131796252 @default.
• W4311628032 cites W3206780619 @default.
• W4311628032 cites W3207272379 @default.
• W4311628032 cites W3210778025 @default.
• W4311628032 cites W3213307883 @default.
• W4311628032 cites W4200126755 @default.
• W4311628032 cites W4200511318 @default.
• W4311628032 cites W4206361515 @default.
• W4311628032 cites W4230818921 @default.
• W4311628032 cites W4281482772 @default.
• W4311628032 cites W4281491954 @default.
• W4311628032 cites W4283719221 @default.
• W4311628032 cites W4295309111 @default.
• W4311628032 cites W4301947847 @default.
• W4311628032 cites W81547946 @default.
• W4311628032 doi "https://doi.org/10.3390/molecules27238558" @default.
• W4311628032 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/36500650" @default.
• W4311628032 hasPublicationYear "2022" @default.
• W4311628032 type Work @default.
• W4311628032 citedByCount "0" @default.
• W4311628032 crossrefType "journal-article" @default.
• W4311628032 hasAuthorship W4311628032A5009624165 @default.
• W4311628032 hasAuthorship W4311628032A5015836766 @default.
• W4311628032 hasAuthorship W4311628032A5022372740 @default.
• W4311628032 hasAuthorship W4311628032A5052073581 @default.
• W4311628032 hasAuthorship W4311628032A5056606353 @default.
• W4311628032 hasAuthorship W4311628032A5073382490 @default.
• W4311628032 hasAuthorship W4311628032A5085042254 @default.
• W4311628032 hasBestOaLocation W43116280321 @default.
• W4311628032 hasConcept C150903083 @default.
• W4311628032 hasConcept C161790260 @default.
• W4311628032 hasConcept C185592680 @default.
• W4311628032 hasConcept C207001950 @default.
• W4311628032 hasConcept C2777496208 @default.
• W4311628032 hasConcept C2780917455 @default.
• W4311628032 hasConcept C2910082039 @default.
• W4311628032 hasConcept C55493867 @default.

• next